CNR2 anticorps (Extracellular, N-Term)
Aperçu rapide pour CNR2 anticorps (Extracellular, N-Term) (ABIN7884844)
Antigène
Voir toutes CNR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Épitope
- AA 11-24, Extracellular, N-Term
-
Fonction
- A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2
-
Homologie
- Canis,bovine - 10,14 amino acid residues identical
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogène
- (C)NGSKDGLDSNPMKD, corresponding to amino acid residues 11-24 of human CB2 receptor
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:200
FC: 2.5 μg per reaction
ICC: 1:50
IHC: The optimal concentration should be determined by the user
IP: The optimal concentration should be determined by the user
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 0.2 mL double distilled water (DDW)
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4
-
Agent conservateur
- Without preservative
-
Stock
- -20 °C
-
Stockage commentaire
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- CNR2 (Cannabinoid Receptor 2 (CNR2))
-
Autre désignation
- CB2
-
Sujet
-
Synonyms: CB2, CNR2
Description: Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.7-9 In human astrocytoma a direct relation between CB2 expression and tumor malignancy was demonstrated.8 Activation of CB2R in vivo by its agonist JWH-133, completely blocked cell growth.8 In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.
-
ID gène
- 1269
-
UniProt
- P34972
Antigène
-